VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 26 filers reported holding VASCULAR BIOGENICS LTD in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $48 | -99.9% | 403,500 | +0.9% | 0.08% | -3.8% |
| Q3 2022 | $62,000 | -67.4% | 400,000 | +239.0% | 0.08% | -64.9% |
| Q2 2022 | $190,000 | +49.6% | 118,000 | +57.3% | 0.22% | +12.5% |
| Q1 2022 | $127,000 | -8.0% | 75,000 | +7.1% | 0.20% | +12.4% |
| Q4 2021 | $138,000 | -27.0% | 70,000 | -23.9% | 0.18% | -30.2% |
| Q3 2021 | $189,000 | -48.2% | 92,000 | -39.8% | 0.26% | -49.2% |
| Q2 2021 | $365,000 | +69.8% | 152,764 | +42.1% | 0.50% | +106.6% |
| Q1 2021 | $215,000 | – | 107,500 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |